BSX : Insider Transactions for Boston Scientific Corp | J3SG

Sign in:	Email	Password save:

		Company Reports
Find Symbol

Recent: Companies Filers Institutions

Membership is free, please Sign Up.

My Recent Searches

Help

Roster

Institutions

Add To Portfolo/Alerts

Get Insiders for :

Boston Scientific Corp (BSX)

$75.00

0.02 (0.03%) as of 4:30 Thu 5/30

Download

Exchange:

New York Stock Exchange

Security Type:

Common

Shares Out:

1,430,000,000

Market Cap:

107.25(B)

Last Volume:

5,150,731

Avg Vol:

8,429,684

52 Week Range:

$48.64 - $75.67

Level I Sector:

Health Care

Level II Sector:

Health Services

Level III Sector:

Medical Instruments & Supplies

Member Indexes:

	S&P COMPOSITE 1500		NYSE COMPOSITE
	S&P 500

Rankings:

Insider 3 Months : -

Insider 6 Months : -

Insider 3/6 Months : -

Guru Rank Number : 297

Guru Rank Value : 4.1

Guru Occurances : 2


6 Months 1 Year 2 Year

Company Profile Boston Scientific develops, manufactures and markets medical devices. Co.'s Medical Surgical segment consist of: Endoscopy, which develops and manufactures devices to diagnose and treat a range of gastrointestinal and pulmonary conditions; and Urology and Pelvic Health, which develops and manufactures devices to treat various urological and pelvic conditions. Co.'s Rhythm and Neuro segment includes: Cardiac Rhythm Management, which develops and manufactures implantable devices to treat cardiac abnormalities; and Electrophysiology, which develops and manufactures medical technologies used in the diagnosis and treatment of rate and rhythm disorders of the heart.

D/I:

D is for direct shares.
I is for indirect shares.

D/I refers to the Direct or Indirect shares traded vs. held.

Forms:

A Form 4 is a form filed by an insider to indicate a change in ownership.

A Form 3 is a form filed by an insider to indicate an initial ownership of a security.

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.

Actions:

B	Buy
S	Sell
OE	Option Exercised
A	Acquired
D	Disposed
AB	Automatic Buy
AS	Automatic Sell
IO	Initial Ownership

Download:

Download only Transactions Forms. (Default)

Download only Summary Infomation.

Download both Transactions and Summary Data

Summary (Direct Transactions Only)	3 Months	6 Months	12 Months	24 Months
Total Shares Bought	0	0	0	0
Total Buy Value	$0	$0	$0	$0
Total People Bought	0	0	0	0
Total Buy Transactions	0	0	0	0
Total Shares Sold	241,206	430,874	929,865	2,041,378
Total Sell Value	$17,733,804	$29,055,549	$55,374,067	$104,875,147
Total People Sold	8	10	11	13
Total Sell Transactions	13	25	42	77
End Date	2024-02-29	2023-11-28	2023-05-30	2022-05-30

Adjust Filter Settings

Records found: 1831

Page 39 of 74

Filer's Name

Relation Title

Off-Dir-10%

D/I

Rank

3m +/-

Form

Nicholas Peter M

Director

– • –

2010-06-22

4

AS

$6.12

$153,058

I/I

(25,000)

8,356,021

-

Nicholas Peter M

Director

– • –

2010-06-21

4

AS

$6.23

$155,650

I/I

(25,000)

8,381,021

-

Phalen Michael P.

SVP & President, Endoscopy

• – –

2010-06-21

4

D

$6.18

$5,408

D/D

(875)

26,572

-

Phalen Michael P.

SVP & President, Endoscopy

• – –

2010-06-21

4

OE

$0.00

$0

D/D

2,751

27,447

-

Director

– • –

2010-06-21

4

AS

$6.23

$467,015

I/I

(75,000)

2,541,949

-

Lance Jean Fitterer

SVP & Chief Compliance Officer

• – –

2010-06-21

4

D

$6.18

$2,973

D/D

(481)

52,893

-

Lance Jean Fitterer

SVP & Chief Compliance Officer

• – –

2010-06-21

4

OE

$0.00

$0

D/D

1,466

53,374

-

Fitzgerald Joseph Michael

SVP & President, Endovascular

• – –

2010-06-21

4

D

$6.18

$1,854

D/D

(300)

35,946

-

Fitzgerald Joseph Michael

SVP & President, Endovascular

• – –

2010-06-21

4

OE

$0.00

$0

D/D

916

36,246

-

Lance Jean Fitterer

SVP & Chief Compliance Officer

• – –

2010-06-21

4

OE

$6.13

$18,148

D/D

2,963

51,908

-

Nicholas Peter M

Director

– • –

2010-06-18

4

AS

$6.15

$153,813

I/I

(25,000)

8,406,021

-

Lance Jean Fitterer

SVP & Chief Compliance Officer

• – –

2010-06-18

4

AS

$6.20

$18,371

D/D

(2,963)

48,945

-

Director

– • –

2010-06-18

4

AS

$6.15

$461,768

I/I

(75,000)

2,616,949

-

Director

– • –

2010-06-17

4

AS

$6.03

$453,095

I/I

(75,000)

2,691,949

-

Nicholas Peter M

Director

– • –

2010-06-17

4

AS

$6.03

$150,870

I/I

(25,000)

8,431,021

-

Capello Jeffrey D

EVP & Chief Financial Officer

• – –

2010-06-16

4

D

$6.10

$157,984

D/D

(25,899)

69,297

-

Capello Jeffrey D

EVP & Chief Financial Officer

• – –

2010-06-16

4

OE

$0.00

$0

D/D

73,314

95,196

-

Director

– • –

2010-06-16

4

AS

$6.06

$454,975

I/I

(75,000)

2,766,949

-

Nicholas Peter M

Director

– • –

2010-06-16

4

AS

$6.07

$151,780

I/I

(25,000)

8,456,021

-

Nicholas Peter M

Director

– • –

2010-06-15

4

AS

$5.96

$149,003

I/I

(25,000)

8,481,021

-

Director

– • –

2010-06-15

4

AS

$5.96

$448,333

I/I

(75,000)

2,841,949

-

Nicholas Peter M

Director

– • –

2010-06-14

4

AS

$5.85

$146,360

I/I

(25,000)

8,506,021

-

Director

– • –

2010-06-14

4

AS

$5.85

$438,930

I/I

(75,000)

2,916,949

-

Director

– • –

2010-06-11

4

AS

$5.65

$424,515

I/I

(75,000)

2,991,949

-

Nicholas Peter M

Director

– • –

2010-06-11

4

AS

$5.65

$141,200

I/I

(25,000)

8,531,021

-

1831 Records found	Previous 30 31 32 33 34 35 36 37 38 39 Next	Page 39 of 74

	Transaction Code Key:				Ownership Code Key
	B	- Buy	AB	- Automatic Buy	D	- Direct Ownership
	S	- Sell	AS	- Automatic Sell	I	- Indirect Ownership
	OE	- Options Exercised	A	- Acquired
	IO	- Initital Ownership	D	- Disposed

Copyright © 2024 j3sg.com | Disclaimer & Terms of use Products & Service About Us Contact Us

Summary:

Chart:

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.